Aripiprazole [Usan] en es it fr

Aripiprazole [Usan] Brand names, Aripiprazole [Usan] Analogs

Aripiprazole [Usan] Brand Names Mixture

  • No information avaliable

Aripiprazole [Usan] Chemical_Formula

C23H27Cl2N3O2

Aripiprazole [Usan] RX_link

http://www.rxlist.com/cgi/generic/abilify.htm

Aripiprazole [Usan] fda sheet

Aripiprazole_[Usan] FDA

Aripiprazole [Usan] msds (material safety sheet)

Aripiprazole [Usan] Synthesis Reference

No information avaliable

Aripiprazole [Usan] Molecular Weight

448.385 g/mol

Aripiprazole [Usan] Melting Point

No information avaliable

Aripiprazole [Usan] H2O Solubility

No information avaliable

Aripiprazole [Usan] State

Solid

Aripiprazole [Usan] LogP

4.537

Aripiprazole [Usan] Dosage Forms

No information avaliable

Aripiprazole [Usan] Indication

For the treatment of schizophrenia

Aripiprazole [Usan] Pharmacology

Aripiprazole is a psychotropic agent belonging to the chemical class of benzisoxazole derivatives and is indicated for the treatment of schizophrenia. Aripiprazole is a selective monoaminergic antagonist with high affinity for the serotonin Type 2 (5HT2), dopamine Type 2 (D2), 1 and 2 adrenergic, and H1 histaminergic receptors. Aripiprazole acts as an antagonist at other receptors, but with lower potency. Antagonism at receptors other than dopamine and 5HT2 with similar receptor affinities may explain some of the other therapeutic and side effects of Aripiprazole. Aripiprazole's antagonism of histamine H1 receptors may explain the somnolence observed with this drug. Aripiprazole's antagonism of adrenergic a1 receptors may explain the orthostatic hypotension observed with this drug.

Aripiprazole [Usan] Absorption

No information avaliable

Aripiprazole [Usan] side effects and Toxicity

No information avaliable

Aripiprazole [Usan] Patient Information

Aripiprazole [Usan] Organisms Affected

Humans and other mammals